Home > Multifetal Pregnancy Reduction
Multifetal pregnancy reduction (MFPR) is a procedure used
to reduce the number of fetuses in a multiple pregnancy, usually to two. When a
pregnancy involves three or more fetuses (high-order pregnancy), the risks of
miscarriage, stillbirth, and lifelong disability increase with each additional
Assisted reproductive technology (ART) and
fertility drugs have greatly increased the number of
The goal of MFPR is to increase
the chance of a successful, healthy pregnancy. Multifetal pregnancy
The most common method of fetal reduction
is transabdominal (through the belly) MFPR. For this procedure, the doctor uses
ultrasound as a guide and inserts a needle through the
woman's abdomen and into the uterus to the selected fetus. The doctor injects
the fetus with a potassium chloride solution, which stops the fetal heart.
Because it is very small during the first trimester, the
dead fetus is usually absorbed by the mother's body. This may include some
vaginal bleeding. This absorption process is the same process that happens in
vanishing twin syndrome.
When there are three or more fetuses in the uterus, their risks of disability or death are higher with each additional fetus. A successful MFPR increases the chances of healthy survival for the remaining fetuses and reduces risks to you. But MFPR sometimes leads to miscarriage of the remaining fetuses, preterm labor, or infection.
The decision to have a multifetal pregnancy reduction is difficult and traumatic. If you are faced with this decision, talk to your doctor about your personal risks from trying to carry multiple fetuses to term compared to the risks of choosing MFPR. Also consider discussing your decision with a counselor or spiritual adviser.
The American Society for
Reproductive Medicine and the American Congress of Obstetricians and
Gynecologists strongly recommend careful use of infertility treatment in the
effort to avoid the risks of a triplet-or-more pregnancy and of MFPR. When
embryos are transferred to the uterus, this means limiting the number of
embryos that are transferred for each treatment cycle.
Health Tools help you make wise health decisions or take action to improve your health.
ByHealthwise StaffPrimary Medical ReviewerKathleen Romito, MD - Family MedicineSpecialist Medical ReviewerWilliam Gilbert, MD - Maternal and Fetal Medicine
Current as ofMarch 16, 2017
Current as of:
March 16, 2017
Kathleen Romito, MD - Family Medicine & William Gilbert, MD - Maternal and Fetal Medicine
To learn more about Healthwise, visit Healthwise.org.
© 1995-2017 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
6051 US Hwy. 49
Hattiesburg, MS 39401
128 Highland Parkway, Suite 202
Picayune, MS 39466
130 Highland Parkway
Picayune, MS 39466
CONNECT WITH FORREST HEALTH
Notice of Privacy Practices · PUBLIC RECORDS REQUEST · FINANCIAL ASSISTANCE · NON-DISCRIMINATION NOTICE
REQUEST FROM LAW ENFORCEMENT FOR RELEASE OF PROTECTED HEALTH INFORMATION 6051 US HIGHWAY 49, HATTIESBURG MS 39401 · 601-288-7000 · © FORREST HEALTH · ALL RIGHTS RESERVED ·